PLSE Jul 2024 20.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2300

0.0000

(0.00%)

At close: 03:39PM EDT

Business Wire
Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
HAYWARD, Calif., June 28, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the preliminary results of its rights offering, which expired at 5:00 p.m., Eastern Time, on June 26, 2024 (the "Expiration Date").
Simply Wall St.
A US$60m drop in the market cap of Pulse Biosciences, Inc. (NASDAQ:PLSE) is not what insiders like to see after purchasing shares recently
Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable...
Simply Wall St.
President & CEO of Pulse Biosciences Burke Barrett Buys More Stock
Even if it's not a huge purchase, we think it was good to see that Burke Barrett, the President & CEO of Pulse...